Portage Announces Increase in Holdings of Portfolio Company, Intensity Therapeutics With Positive Business, Regulatory, & Clinical Updates

Published: 11/07/2019
Portage Announces Increase in Holdings of Portfolio Company, Intensity Therapeutics With Positive Business, Regulatory, & Clinical Updates
Source: WWW.PRNEWSWIRE.COM

Purchase of Intensity Therapeutics shares via acquisition of Intensity Holdings Limited, and a new research collaboration with Merck, highlight recent milestones TORONTO, July 11, 2019 /PRNewswire/ - Portage Biotech Inc., ("Portage" or the "Company") (CSE: PBT.U, OTC Markets: PTGEF) today ...

Read more
Related news
Comment
FACEBOOK